Comunicati ACCORD and HIPRA Enter into Exclusive Distribution Agreement to Commercialise HIPRA’s COVID-19 vaccine (BIMERVAX®) in the United Kingdom
Comunicati The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China.